Clinical Comparison of 99Tcm-Hmpao Labelled Leucocytes and 99Tcm-Nanocolloid in the Detection of Inflammation
- 1 November 1989
- journal article
- research article
- Published by SAGE Publications in Acta Radiologica
- Vol. 30 (6) , 633-637
- https://doi.org/10.1177/028418518903000612
Abstract
Forty-five patients with various inflammatory diseases were imaged with 99Tcm-HMPAO labelled leucocytes and 99Tcm-nanocolloid within 7 days. The overall sensitivity of 99Tcm-leucocytes was 97% and that of 99Tcm-nanocolloid 59% and both agents had a 100% specificity. The 99Tcm-leucocyte method showed reliable results in various inflammatory and infectious conditions, and seems suitable as a primary imaging method. On the contrary, 99Tcm-nanocolloid cannot be recommended for use in inflammatory bowel diseases, soft tissue abscesses or prosthetic vascular graft infections. However, 99Tcm-nanocolloid gave reliable information in inflammatory and infectious bone and joint diseases in which it had a 90% sensitivity and 100% specificity. In those lesions the 99Tcm-nanocolloid method may be useful, because it is simple, fast and cheap. Yet, further evaluation is needed.Keywords
This publication has 5 references indexed in Scilit:
- Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in manNuclear Medicine Communications, 1988
- 99Tcm-HMPAO labelled leucocytesNuclear Medicine Communications, 1988
- Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes.Radiology, 1988
- Scintigraphy of inflammation with nanometer-sized colloidal tracersNuclear Medicine Communications, 1987
- CLINICAL EXPERIENCE WITH 99mTc-HEXAMETHYLPROPYLENE-AMINEOXIME FOR LABELLING LEUCOCYTES AND IMAGING INFLAMMATIONThe Lancet, 1986